nalidixic acid has been researched along with fluorouracil in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Davies, J; Schindler, D | 1 |
| Heinonen, J; Kukko, E | 1 |
| MacNaughton, AW; Winder, FG | 1 |
| Kaasch, J; Kaasch, M; Quiñones, A | 1 |
| Donch, J; Green, MH; Greenberg, J | 1 |
| Abramson, IJ; Smibert, RM | 1 |
| Kukko, E; Saarento, H | 1 |
| Arking, R; Kalata, K; Parente, A | 1 |
| Dahan-Grobgeld, E; Degani, H; Eichenbaum, Z; Livneh, Z; Maretzek, AF; Polak-Charcon, S | 1 |
2 review(s) available for nalidixic acid and fluorouracil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Inhibitors of macromolecular synthesis in yeast.
Topics: Acriflavine; Amphotericin B; Anisomycin; Anti-Bacterial Agents; Antineoplastic Agents; Cycloheximide; Dactinomycin; Daunorubicin; Deoxyadenosines; Depression, Chemical; DNA; Ethidium; Fluorouracil; Fungal Proteins; Hydroxyurea; Mitomycins; Nalidixic Acid; Phenazines; Phenylethyl Alcohol; Porfiromycin; Puromycin; RNA; Saccharomyces cerevisiae; Streptonigrin; Sulfanilamides; Triaziquone; Trichothecenes; Uracil | 1975 |
17 other study(ies) available for nalidixic acid and fluorouracil
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Partial inhibition of DNA synthesis gives rise to increase in the level of inorganic pyrophosphatase in the growing cells of Escherichia coli.
Topics: Depression, Chemical; DNA, Bacterial; Escherichia coli; Fluorouracil; Mitomycins; Nalidixic Acid; Pyrophosphatases; Thymine; Trimethoprim | 1977 |
Increased DNA polymerase and ATP-dependent deoxyribonuclease activities following DNA damages in mycobacterium smegmatis.
Topics: Acridines; Adenosine Triphosphate; Bacterial Proteins; Caffeine; Deoxyribonucleases; DNA-Directed DNA Polymerase; DNA, Bacterial; Ethidium; Ethyl Methanesulfonate; Fluorouracil; Mechlorethamine; Methyl Methanesulfonate; Mitomycins; Mutation; Mycobacterium; Nalidixic Acid; Proflavine; Ultraviolet Rays | 1977 |
Expression of the dnaN and dnaQ genes of Escherichia coli is inducible by mitomycin C.
Topics: DNA Damage; DNA Polymerase III; DNA Repair; DNA-Directed DNA Polymerase; Enzyme Induction; Escherichia coli; Fluorouracil; Gene Expression Regulation, Enzymologic; Mitomycin; Mitomycins; Mutation; Nalidixic Acid; SOS Response, Genetics | 1989 |
Effect of inhibitors of DNA synthesis of UV-sensitive derivatives of Escherichia coli strain K-12.
Topics: DNA; Drug Resistance, Microbial; Escherichia coli; Fluorouracil; Nalidixic Acid; Radiation Effects; Recombination, Genetic; Starvation; Thymine; Ultraviolet Rays | 1970 |
Inhibition of growth of treponemes by antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Benzofurans; Coloring Agents; Drug Resistance, Microbial; Feces; Fluorouracil; Furazolidone; Humans; Methenamine; Mouth; Muramidase; Nalidixic Acid; Nitrofurazone; Rabbits; Sulfonamides; Sulfonic Acids; Swine; Thallium; Tolonium Chloride; Treponema; Uracil | 1971 |
Diphosphate concentration does not correlate with the level of inorganic diphosphatase in Escherichia coli.
Topics: Diphosphates; DNA Replication; Escherichia coli; Fluorouracil; Inorganic Pyrophosphatase; Kinetics; Mutation; Nalidixic Acid; Pyrophosphatases; Transcription, Genetic; Uracil | 1984 |
Effect of DNA inhibitors upon DNA synthesis and development of Drosophila embryos.
Topics: Age Factors; Animals; Arabinonucleotides; Cytidine Monophosphate; DNA; Drosophila melanogaster; Fluorouracil; Mitomycins; Nalidixic Acid; Thymidine; Time Factors | 1980 |
Reversible induction of ATP synthesis by DNA damage and repair in Escherichia coli. In vivo NMR studies.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Bacterial Proteins; DNA Damage; DNA Repair; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Exodeoxyribonuclease V; Exodeoxyribonucleases; Fluorouracil; Magnetic Resonance Spectroscopy; Nalidixic Acid; Serine Endopeptidases; SOS Response, Genetics | 1998 |